Changes of serum omentin-1 levels in normal subjects, type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults

Annales d'Endocrinologie

Volumn 75, Issue 3, 2014, Pages 171-175

  Zhang, Qiang ^a   Zhu, Lei ^b   Zheng, Min ^a   Fan, Chaohua ^a   Li, Yunhao ^a   Zhang, Dan ^a   He, Yanming ^a   Yang, Hongjie ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Department of Chinese Medicine   (China)

Author keywords

Adipokines; Insulin and diabetes; Omentin

Indexed keywords

ADIPOCYTOKINE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OMENTIN 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO;

EID: 84922757562     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2014.04.013     Document Type: Article

References (21)

1. Zimmet P., Alberti K.G., Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001, 414:782-787.
2. Antuna-Puente B., Feve B., Fellahi S., Bastard J.P. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab 2008, 34:2-11.
3. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89:2548-2556.
4. Fukuhara A., Matsuda M., Nishizawa M., Segawa K., Tanaka M., Kishimoto K., et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005, 307:426-430.
5. Heidemann C., Sun Q., van Dam R.M., Meigs J.B., Zhang C., Tworoger S.S., et al. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med 2008, 149:307-316.
6. Wannamethee S.G., Lowe G.D., Rumley A., Cherry L., Whincup P.H., Sattar N. Adipokines and risk of type 2 diabetes in older men. Diabetes Care 2007, 30:1200-1205.
7. Ahima R.S., Lazar M.A. Adipokines and the peripheral and neural control of energy balance. Mol Endocrinol 2008, 22:1023-1031.
8. Hivert M.F., Sullivan L.M., Fox C.S., Nathan D.M., D'Agostino R.B., Wilson P.W., et al. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 2008, 93:3165-3172.
9. Lorenzo M., Fernandez-Veledo S., Vila-Bedmar R., Garcia-Guerra L., De Alvaro C., Nieto-Vazquez I. Insulin resistance induced by tumor necrosis factor-alpha in myocytes and brown adipocytes. J Anim Sci 2008, 86:E94-E104.
10. Wang K.L., Liu C.J., Chao T.F., Huang C.M., Wu C.H., Chen S.J., et al. Statins, risk of diabetes, and implications on outcomes in the general population. J Am Coll Cardiol 2012, 60:1231-1238.
11. Yang R.Z., Lee M.J., Hu H., Pray J., Wu H.B., Hansen B.C., et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 2006, 290:E1253-E1261.
12. Fu M., Damcott C.M., Sabra M., Pollin T.I., Ott S.H., Wang J., et al. Polymorphism in the calsequestrin 1 (CASQ1) gene on chromosome 1q21 is associated with type 2 diabetes in the old order Amish. Diabetes 2004, 53:3292-3299.
13. Xiang K., Wang Y., Zheng T., Jia W., Li J., Chen L., et al. Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes 2004, 53:228-234.
14. Vionnet N., Hani E.H., Dupont S., Gallina S., Francke S., Dotte S., et al. Genome-wide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2 diabetes locus on chromosome 1q21-q24. Am J Hum Genet 2000, 67:1470-1480.
15. de Souza Batista C.M., Yang R.Z., Lee M.J., Glynn N.M., Yu D.Z., Pray J., et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes 2007, 56:1655-1661.
16. Pan H.Y., Guo L., Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 2010, 88:29-33.
17. Tan B.K., Pua S., Syed F., Lewandowski K.C., O'Hare J.P., Randeva H.S. Decreased plasma omentin-1 levels in Type 1 diabetes mellitus. Diabet Med 2008; 2008, 25:1254-1255.
18. Moreno-Navarrete J.M., Catalan V., Ortega F., Gomez-Ambrosi J., Ricart W., Fruhbeck G., et al. Circulating omentin concentration increases after weight loss. Nutr Metab 2010, 7:27.
19. Tan B.K., Adya R., Farhatullah S., Lewandowski K.C., O'Hare P., Lehnert H., et al. Omentin-1, a novel adipokine, is decreased in overweight insulin-resistant women with polycystic ovary syndrome: ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes 2008, 57:801-808.
20. Alberti K.G., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15:539-553.
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.